000			01823pam a2200277 a 4500
005			20250914134716.0
008			040908s2004 xxka b 001 0 eng b
020			_a044307240X _cRM222.53
039		9	_a200503231831 _bwahab _c200503151021 _dzainol _y09-08-2004 _zfida
060			_aQV736
090			_aQV736.P537 2004
245	0	0	_aPharmacoeconomics / _cedited by Tom Walley, Alan Haycox, Angela Boland ; foreword by Alasdair M. Breckenridge
260			_aEdinburgh : _bChurchill Livingstone, _c2004
300			_axii, 203 p. : _bill. ; _c24 cm.
505	0		_aBasics of economics, health economics, and pharmacoeconomics / Alan Haycox, Angela Boland and Tom Walley -- The economics of health care and healthcare systems / Ruth McDonald and Tom Walley -- The policy context for pharmacoeconomics / Ruth McDonald and Tom Walley -- Pharmacoeconomics : an industry perspective / Pippa Anderson, Adam Lloyd, and David Grant -- Disease management and the technique of programme budgeting and marginal analysis / Ruth McDonald, Steve Chapman, and Julia Bottomley -- Cost of illness studies / Tom Walley and Judith Strobl -- Approaches to pharmacoeconomic analysis / Dyfrig Hughes, Antonieta Medina Lara, and Ruben Mujica-Mota -- Pharmacoeconomics and clinical trials / Alan Haycox and Adrian Bagust -- Modelling in health economics / Dyfrig Hughes -- Quality assurance in pharmacoeconomic analyses / Alan Haycox -- The future challenges / Prescribing Research Group
650		2	_aEconomics, Pharmaceutical
700	1		_aWalley, Tom
700	1		_aHaycox, Alan, _d1957-
700	1		_aBoland, Angela
907			_a.b13428718 _b2019-11-12 _c2019-11-12
942			_c01 _n0 _kQV736.P537 2004
914			_avtls003294711
991			_aJabatan Farmasi
998			_ad _b2004-08-09 _cm _da _feng _gxxk _y0 _z.b13428718
999			_c342146 _d342146